Finance
Germany's DHL to acquire US pharma logistics firm Cryopdp
Published by Global Banking & Finance Review®
Posted on March 31, 2025
1 min readLast updated: January 24, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on March 31, 2025
1 min readLast updated: January 24, 2026
DHL acquires Cryopdp to expand its pharma logistics, enhancing its Life Sciences and Healthcare segments. The deal awaits regulatory approval.
DUSSELDORF, Germany (Reuters) -DHL said on Monday it will acquire U.S. pharmaceutical logistics firm Cryopdp as part of the German company's efforts to grow its operations in the pharma sector, confirming an earlier report by Reuters.
DHL did not disclose a purchase price for the deal, which foresees the German logistics giant buying 100% of the specialty courier. A source familiar with the matter told Reuters that DHL would pay a three-digit million-euro sum.
The companies have also agreed to a strategic partnership to strengthen their supply chain service offerings for the global life sciences and healthcare sector, DHL said in a statement.
Cryopdp ships products for pharmaceutical and biotech companies, as well as offering storage and packaging services.
DHL hopes the deal will strengthen its Life Sciences and Healthcare segments, which generated over 5 billion euros ($5.41 billion) in revenue in 2024.
The deal and the outlined partnership are subject to regulatory approvals, the company said.
($1 = 0.9247 euros)
(Reporting by Matthias Inverardi, Writing by Rachel More, Editing by Thomas Seythal, Kirsten Donovan)
The main topic is DHL's acquisition of Cryopdp to expand its pharmaceutical logistics operations.
Cryopdp specializes in shipping products for pharmaceutical and biotech companies, as well as offering storage and packaging services.
DHL is acquiring Cryopdp to strengthen its Life Sciences and Healthcare segments and enhance its supply chain service offerings.
Explore more articles in the Finance category
